February 12, 2018 / 1:20 PM / 10 months ago

BRIEF-Teva Launches Qvar Redihaler Inhalation Aerosol In U.S.

Feb 12 (Reuters) - Teva Pharmaceutical Industries Ltd :

* TEVA ANNOUNCES U.S. LAUNCH OF QVAR® REDIHALER™ (BECLOMETHASONE DIPROPIONATE HFA) INHALATION AEROSOL

* WITH LAUNCH OF QVAR REDIHALER, TEVA IS DISCONTINUING SALES OF PREVIOUSLY AVAILABLE QVAR

* QVAR REDIHALER WILL BE PRICED AT PARITY TO QVAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below